Medicare Enrolled

Dr. Fernando Gamarra, MD

Gastroenterology · Clinton Twp, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
37399 GARFIELD RD STE 104, Clinton Twp, MI 48036
5862865400
In practice since 2007 (19 years)
NPI: 1457473654 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gamarra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gamarra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gamarra

Dr. Fernando Gamarra is a gastroenterology specialist in Clinton Twp, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gamarra performed 498 Medicare services across 462 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gamarra received a total of $11,559 from 47 pharmaceutical and/or device companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gamarra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 46% volume in MI $11,559 industry payments

Medicare Practice Summary

Medicare Utilization ↗
498
Medicare services
Top 46% in MI for gastroenterology
462
Unique beneficiaries
$125
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
104 $210 $747
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
68 $66 $85
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $92 $135
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
56 $87 $405
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
56 $138 $220
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
36 $86 $340
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
28 $171 $560
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $68 $100
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
18 $71 $567
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
15 $194 $560
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $108 $150
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
11 $143 $560
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $118 $185
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,559
Total received (2018-2024)
Avg $1,651/year across 7 years
Top 14% in MI for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
666
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,544 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,733
2023
$2,650
2022
$2,151
2021
$1,395
2020
$251
2019
$1,246
2018
$1,134

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$783
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$422
Takeda Pharmaceuticals U.S.A., Inc.
$305
Janssen Biotech, Inc.
$283
Ardelyx, Inc.
$154
PFIZER INC.
$117
GENZYME CORPORATION
$100
QOL Medical, LLC
$83
Intercept Pharmaceuticals, Inc.
$83
Celgene Corporation
$74
AIMMUNE THERAPEUTICS, INC.
$56
Ipsen Biopharmaceuticals, Inc
$50
Lilly USA, LLC
$44
Gilead Sciences, Inc.
$39
Merck Sharp & Dohme LLC
$34
Regeneron Healthcare Solutions, Inc.
$32
Daiichi Sankyo Inc.
$25
Braintree Laboratories, Inc.
$19
VIVUS LLC
$16
CapsoVision, Inc.
$14
Top 3 companies account for 55.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,039
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,544
Takeda Pharmaceuticals U.S.A., Inc.
$1,211
Janssen Biotech, Inc.
$991
PFIZER INC.
$740
Gilead Sciences, Inc.
$517
Braintree Laboratories, Inc.
$454
Celgene Corporation
$437
AbbVie, Inc.
$419
QOL Medical, LLC
$356
AbbVie Inc.
$327
Ardelyx, Inc.
$315
GENZYME CORPORATION
$303
Ferring Pharmaceuticals Inc.
$172
Intercept Pharmaceuticals, Inc.
$172
Regeneron Healthcare Solutions, Inc.
$165
INTERCEPT PHARMACEUTICALS, INC.
$111
Merck Sharp & Dohme LLC
$108
Allergan Inc.
$107
Endogastric Solutions, Inc
$100
Daiichi Sankyo Inc.
$80
Fresenius Kabi USA, LLC
$75
UCB, Inc.
$68
AIMMUNE THERAPEUTICS, INC.
$56
RedHill Biopharma Inc.
$51
Ipsen Biopharmaceuticals, Inc
$50
Lilly USA, LLC
$44
Mylan Institutional Inc.
$43
Nestle HealthCare Nutrition Inc.
$39
Allergan, Inc.
$39
Evoke Pharma, Inc.
$38
NESTLE HEALTHCARE NUTRITION INC.
$37
Ironwood Pharmaceuticals, Inc
$34
Medtronic, Inc.
$30
Alexion Pharmaceuticals, Inc.
$30
Shionogi Inc
$28
CapsoVision, Inc.
$28
Shire North American Group Inc
$27
Romark Laboratories, LC
$27
Synergy Pharmaceuticals Inc
$26
Organon LLC
$25
Amgen Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Echosens North America, Inc.
$16
VIVUS LLC
$16
Novo Nordisk Inc
$12
EVOKE PHARMA, INC.
$11
Top 3 companies account for 41.5% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CREON · CYCLOSET · CYLTEZO · CapsoCam Plus · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · ESOPHYX · Entyvio · FibroScan · GATTEX · GI Genius · GIMOTI · HADLIMA · HUMIRA · Hulio · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · IQIRVO · Kanuma · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Mulpleta · OCALIVA · OMVOH · PLENVU · QSYMIA · REBYOTA · RELISTOR · REMICADE · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Saxenda · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Clinton Twp?
Compare gastroenterologists in the Clinton Twp area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
134
Per 100K population
15.3
County median income
$76,399
Nearest hospital
HENRY FORD MACOMB HOSPITAL
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gamarra is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gamarra experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Gamarra performed 104 colon polyp removal with endoscopic snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gamarra receive payments from pharmaceutical companies?
Yes. Dr. Gamarra received a total of $11,559 from 47 companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gamarra's costs compare to other gastroenterologists in Clinton Twp?
Dr. Gamarra's average Medicare payment per service is $125. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gamarra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →